Cargando…
Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies
Vasoactive intestinal peptide (VIP) plays diverse and important role in human physiology and physiopathology and their receptors constitute potential targets for the treatment of several diseases such as neurodegenerative disorder, asthma, diabetes, and inflammatory diseases. This article reviews th...
Autor principal: | Langer, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483716/ https://www.ncbi.nlm.nih.gov/pubmed/23115557 http://dx.doi.org/10.3389/fendo.2012.00129 |
Ejemplares similares
-
Development by Genetic Immunization of Monovalent Antibodies Against Human Vasoactive Intestinal Peptide Receptor 1 (VPAC1), New Innovative, and Versatile Tools to Study VPAC1 Receptor Function
por: Peyrassol, Xavier, et al.
Publicado: (2018) -
An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance
por: Gomariz, Rosa P., et al.
Publicado: (2019) -
The VPAC1 receptor: structure and function of a class B GPCR prototype
por: Couvineau, A., et al.
Publicado: (2012) -
Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes
por: Hou, Xintong, et al.
Publicado: (2022) -
Role of VPAC1 and VPAC2 receptors in the etiology of pregnancy rhinitis: an experimental study in rats
por: Ulkumen, Burak, et al.
Publicado: (2020)